Advertisement

Ads Placeholder
Loading...

Euroapi S.A.

EAPI.PAEURONEXT
Healthcare
Medical - Devices
1.26
-0.04(-3.08%)
U.S. Market opens in 7h 40m

Euroapi S.A. Fundamental Analysis

Euroapi S.A. (EAPI.PA) shows weak financial fundamentals with a PE ratio of -0.57, profit margin of -24.83%, and ROE of -24.26%. The company generates $0.9B in annual revenue with weak year-over-year growth of -9.79%.

Key Strengths

Cash Position94.98%
PEG Ratio0.01
Current Ratio2.60

Areas of Concern

ROE-24.26%
Operating Margin-4.23%
We analyze EAPI.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -22.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-22.7/100

We analyze EAPI.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

EAPI.PA struggles to generate sufficient returns from assets.

ROA > 10%
-16.19%

Valuation Score

Excellent

EAPI.PA trades at attractive valuation levels.

PE < 25
-0.57
PEG Ratio < 2
0.01

Growth Score

Moderate

EAPI.PA shows steady but slowing expansion.

Revenue Growth > 5%
-9.79%
EPS Growth > 10%
30.85%

Financial Health Score

Excellent

EAPI.PA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.08
Current Ratio > 1
2.60

Profitability Score

Weak

EAPI.PA struggles to sustain strong margins.

ROE > 15%
-2425.63%
Net Margin ≥ 15%
-24.83%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is EAPI.PA Expensive or Cheap?

P/E Ratio

EAPI.PA trades at -0.57 times earnings. This suggests potential undervaluation.

-0.57

PEG Ratio

When adjusting for growth, EAPI.PA's PEG of 0.01 indicates potential undervaluation.

0.01

Price to Book

The market values Euroapi S.A. at 0.15 times its book value. This may indicate undervaluation.

0.15

EV/EBITDA

Enterprise value stands at 1.19 times EBITDA. This is generally considered low.

1.19

How Well Does EAPI.PA Make Money?

Net Profit Margin

For every $100 in sales, Euroapi S.A. keeps $-24.83 as profit after all expenses.

-24.83%

Operating Margin

Core operations generate -4.23 in profit for every $100 in revenue, before interest and taxes.

-4.23%

ROE

Management delivers $-24.26 in profit for every $100 of shareholder equity.

-24.26%

ROA

Euroapi S.A. generates $-16.19 in profit for every $100 in assets, demonstrating efficient asset deployment.

-16.19%

Following the Money - Real Cash Generation

Operating Cash Flow

Euroapi S.A. produces operating cash flow of $127.46M, showing steady but balanced cash generation.

$127.46M

Free Cash Flow

Euroapi S.A. produces free cash flow of $48.55M, offering steady but limited capital for shareholder returns and expansion.

$48.55M

FCF Per Share

Each share generates $0.51 in free cash annually.

$0.51

FCF Yield

EAPI.PA converts 40.10% of its market value into free cash.

40.10%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.57

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.008

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.15

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.14

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.08

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.60

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.24

vs 25 benchmark

ROA

Return on assets percentage

-0.16

vs 25 benchmark

ROCE

Return on capital employed

-0.04

vs 25 benchmark

How EAPI.PA Stacks Against Its Sector Peers

MetricEAPI.PA ValueSector AveragePerformance
P/E Ratio-0.5728.54 Better (Cheaper)
ROE-24.26%738.00% Weak
Net Margin-24.83%-43982.00% (disorted) Weak
Debt/Equity0.080.34 Strong (Low Leverage)
Current Ratio2.602806.01 Strong Liquidity
ROA-16.19%-14624.00% (disorted) Weak

EAPI.PA outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Euroapi S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-0.13%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-5297.85%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

250.39%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ